Kiniksa Pharmaceuticals L... (KNSA)
NASDAQ: KNSA
· Real-Time Price · USD
35.54
0.03 (0.08%)
At close: Sep 05, 2025, 12:46 PM
Kiniksa Pharmaceuticals Revenue
Kiniksa Pharmaceuticals reported an annual revenue of $423.24M, reflecting a 56.6% growth. For the quarter ending June 30, 2025, Kiniksa Pharmaceuticals generated $156.8M in revenue.
Revenue (ttm)
423.24M
Revenue Growth
56.6%
Price / Sales Ratio
3.34
Revenue / Employee
1.34M
Employees
315
Market Cap
2.63B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 423.24M | +56.60% |
| Dec 31, 2023 | 270.26M | +22.74% |
| Dec 31, 2022 | 220.18M | +471.24% |
| Dec 31, 2021 | 38.54M | +Infinity% |
| Dec 31, 2020 | 0 | n/a |
| Dec 31, 2019 | 0 | n/a |
| Dec 31, 2018 | 0 | n/a |
| Dec 31, 2017 | 0 | n/a |
| Dec 31, 2016 | 0 | n/a |